Document and Entity Information
Document and Entity Information | May 23, 2024 |
Document And Entity Information [Line Items] | |
Document Type | 8-K |
Document Period End Date | May 23, 2024 |
Entity Registrant Name | MEREO BIOPHARMA GROUP PLC |
Entity Incorporation State Country Code | X0 |
Entity File Number | 001-38452 |
Entity Tax Identification Number | 00-0000000 |
Entity Address Address Line 1 | 4th Floor |
Entity Address Address Line 2 | One Cavendish Place |
Entity Address City Or Town | London |
Entity Address Postal Zip Code | W1G 0QF |
Entity Address Country | GB |
Country Region | 44 |
City Area Code | 333 |
Local Phone Number | 023-7300 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | true |
Amendment Flag | false |
Entity Central Index Key | 0001719714 |
American Depositary Shares, each representing five Ordinary Shares, par value £0.003 per share [Member] | |
Document And Entity Information [Line Items] | |
Security 12b Title | American Depositary Shares, each representing five Ordinary Shares, par value £0.003 per share |
Trading Symbol | MREO |
Security Exchange Name | NASDAQ |
Ordinary Shares, nominal value £0.003 per share [Member] | |
Document And Entity Information [Line Items] | |
Security 12b Title | Ordinary Shares, nominal value £0.003 per share |
Security Exchange Name | NASDAQ |
No Trading Symbol Flag | true |